Market Overview

UPDATE: Citigroup Initiates Coverage On PRA Health Sciences On Ingredients For Success

Share:

In a report published Monday, Citigroup analyst Garen Sarafian initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with a Neutral rating and $24.00 price target.

In the report, Citigroup noted, “We are initiating on PRA Health Sciences with a Neutral rating and a $24 target price. PRAH, a Contract Research Organization (CRO), is performing well after its mid-2013 acquisition of peer ReSearch Pharmaceutical Services (RPS), allowing it to compete more closely with the world's largest and most diversified CROs. The acquisition also provided key exposure to top biopharmaceutical clients, complementary to legacy PRAs position with small/mid-sized biotechs. While we favor PRA's clinical focus & believe global CROs will benefit disproportionately from macro trends including our proprietary analysis of global drug trial starts, our relative view of valuations in the CRO subsector and PRA's ~20% price appreciation post-IPO keep us on the sidelines.”

PRA Health Sciences closed on Friday at $22.06.

Latest Ratings for PRAH

DateFirmActionFromTo
Sep 2019UpgradesSector WeightOverweight
Sep 2019MaintainsOverweight
May 2019DowngradesOverweightSector Weight

View More Analyst Ratings for PRAH
View the Latest Analyst Ratings

Posted-In: Citigroup Garen SarafianAnalyst Color Initiation Analyst Ratings

 

Related Articles (PRAH)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
IINDoughertyAssumes34.0
PNRJefferiesInitiates Coverage On
YYUBSUpgrades
ROKUOppenheimerMaintains155.0
IPHIBank of AmericaMaintains80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: Vail Resorts Posts Narrower Q1 Loss

5 Utilities Stocks With The Highest EPS